Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer Frederik A. VerburgCumali Aktolunon behalf of the EANM and the EANM Thyroid Committee Editorial 17 February 2016 Pages: 1001 - 1005
Evaluation of 124I PET/CT and 124I PET/MRI in the management of patients with differentiated thyroid cancer Laurent DercleDésirée DeandreisMartin Schlumberger Editorial Commentary 01 March 2016 Pages: 1006 - 1010
Imaging with 124I in differentiated thyroid carcinoma: is PET/MRI superior to PET/CT? I. BinseT. D. PoeppelS. J. Rosenbaum-Krumme Original Article 19 December 2015 Pages: 1011 - 1017
Molecular imaging with 99mTc-MIBI and molecular testing for mutations in differentiating benign from malignant follicular neoplasm: a prospective comparison L. GiovanellaA. CampenniM. Bongiovanni Original Article Open access 23 December 2015 Pages: 1018 - 1026
18F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma Aurélien ArchierCéline HeimburgerDavid Taïeb Original Article 24 October 2015 Pages: 1027 - 1033
Noninferior response in BRAFV600E mutant nonmetastatic papillary thyroid carcinoma to radioiodine therapy Jiao LiJun LiangYansong Lin Original Article 16 January 2016 Pages: 1034 - 1039
Peptide receptor radionuclide therapy with 177Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and 18F-FDG PET Annarita IannielloMaddalena SansoviniGiovanni Paganelli Original Article 27 November 2015 Pages: 1040 - 1046
Pilot prospective evaluation of 18F-FPPRGD2 PET/CT in patients with cervical and ovarian cancer Ryogo MinamimotoAmer KaramAndrei Iagaru Original Article 27 November 2015 Pages: 1047 - 1055
Is dopamine transporter invariably impaired at the time of diagnosis in dementia with Lewy bodies? Flavio NobiliDario ArnaldiSilvia Morbelli Editorial Commentary 09 February 2016 Pages: 1056 - 1059
[123]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies J. J. van der ZandeJ. BooijA. W. Lemstra Original Article Open access 30 January 2016 Pages: 1060 - 1066
Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: 18F-florbetapir (AV-45/Amyvid) PET study Kuan-Yi WuChia-Yih LiuKun-Ju Lin Original Article 07 January 2016 Pages: 1067 - 1076
Evaluation of software tools for automated identification of neuroanatomical structures in quantitative β-amyloid PET imaging to diagnose Alzheimer’s disease Tobias TuszynskiMichael RullmannHenryk Barthel Original Article 07 January 2016 Pages: 1077 - 1087
Amyloid-independent functional neural correlates of episodic memory in amnestic mild cognitive impairment Eun Hyun SeoIL Han ChooFor the Alzheimer’s Disease Neuroimaging Initiative Original Article 28 November 2015 Pages: 1088 - 1095
Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [11C] DASB positron emission tomography study Swen HesseMichael RullmannOsama Sabri Original Article 18 November 2015 Pages: 1096 - 1104
Early static 18F-FET-PET scans have a higher accuracy for glioma grading than the standard 20–40 min scans Nathalie L. AlbertIsabel WinkelmannChristian la Fougère Original Article 15 December 2015 Pages: 1105 - 1114
Reproducibility of O-(2-18F-fluoroethyl)-L-tyrosine uptake kinetics in brain tumors and influence of corticoid therapy: an experimental study in rat gliomas Carina StegmayrMichael SchöneckKarl-Josef Langen Original Article 08 December 2015 Pages: 1115 - 1123
In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis Abraham MartínNuria Vázquez-VilloldoCarlos Matute Original Article 10 December 2015 Pages: 1124 - 1138
Tau imaging in neurodegenerative diseases M. DaniD. J. BrooksP. Edison Review Article Open access 16 November 2015 Pages: 1139 - 1150
Metabotropic glutamate receptor 5 – a promising target in drug development and neuroimaging Rajapillai L. I. PillaiDnyanesh N. Tipre Review Article 07 January 2016 Pages: 1151 - 1170
Current status of PET imaging in Huntington’s disease Gennaro PaganoFlavia NiccoliniMarios Politis Review Article Open access 22 February 2016 Pages: 1171 - 1182
Imaging of differentiated thyroid carcinoma: 124I-PET/MRI may not be superior to 124I-PET/CT A. VrachimisM. WeckesserL. Stegger Letter to the Editor 26 January 2016 Pages: 1183 - 1184
Imaging of differentiated thyroid carcinoma: 124I-PET/MRI may not be superior to 124I-PET/CT Ina BinseSandra Julia Rosenbaum-KrummeAndreas Bockisch Reply 03 February 2016 Pages: 1185 - 1186
18F-DOPA: the versatile radiopharmaceutical David TaïebAlessio ImperialeKarel Pacak Letter to the Editor 11 March 2016 Pages: 1187 - 1189
Rudy A.J.O. Dierckx, Andreas Otte, Erik F.J. de Vries, Aren van Waarde (eds); guest editor Klaus L. Leenders: PET and SPECT in Neurology Christian MarsigliaLuigi Mansi Book Review 26 February 2016 Pages: 1190 - 1191
Mauro Papotti and Wouter W. De Herder (ed): Neuroendocrine Tumors: A Multidisciplinary Approach Roberto VignapianoLuigi Mansi Book Review 26 February 2016 Pages: 1192 - 1192
The Pathophysiologic Basis of Nuclear Medicine, Third Edition, Abdelhamid H. Elgazzar, Ed. Alessia RuggieroLuigi Mansi Book Review 26 February 2016 Pages: 1193 - 1193